Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Health and Safety
- Environmental
- Manufacturing, Other
- Banking & Finance / Insurance / Legal
- Defense
- Aerospace & Air Transport
- Retail
- Waste and Recycling
- Agriculture
- Air and Climate
- Soil and Groundwater
- University / Academia / Research
- Food and Beverage
- Energy
- Construction & Construction Materials
Development And Clinical Suppliers Serving Ghana
200 companies found
based inSan Diego, CALIFORNIA (USA)
NuVasive, Inc. is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and ...
based inNottingham, UNITED KINGDOM
ViVO Smart Medical Devices is the UK’s leading design-to-manufacturing company converting ideas & clinical needs into innovative medical devices. We provide design, technology and manufacturing expertise to Medtech Companies and Healthcare ...
based inLausanne, SWITZERLAND
Amazentis is an innovative life science company dedicated to employing breakthrough research and clinical science to bring advanced therapeutic nutrition products to life. We employ rigorous science to pioneer the discovery and clinical development ...
based inSurrey, UNITED KINGDOM
Ergomed is focused on providing specialised services to the biopharmaceutical industry. Ergomed is a global provider of expert, high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval ...
Global regulatory framework assessment tool. This heat-map assesses the suitability of the country's regulatory framework based on your protocol. Simply enter details of your trial design to see which countries will facilitate fast approval and ...
based inShirley, NEW YORK (USA)
CD BioSciences is committed to fulfilling all your demands in the research of signaling pathways. We provide high-quality reagents, one-stop services and comprehensive solutions to support your innovative discoveries. Our mission is to provide our ...
based inXiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
based inChaska,, MINNESOTA (USA)
Lifecore Biomedical is a full-service contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to develop and deliver vital and complex injectable therapies. For more than 30 years, we have ...
Drug product formulation development starts with an understanding of the drug substance. Our experts work with you to define and understand the anticipated use, desired performance criteria, characteristics of the drug product, distribution, ...
based inGenoa, ITALY
Movendo Technology: the development of clinical technology. Combining research, applied technology and clinical development has allowed Movendo to consolidate a unique position in the global market. Movendo Technology draws on the technical ...
based inSomerset, NEW JERSEY (USA)
As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, we conduct all our business responsibly and with integrity. Our ...
The biologics market is experiencing high growth. However, the path to clinic for biologics is complex, requiring a substantial amount of time and resources to ensure success. Sponsor companies are looking for an “all of the ...
based inCambridge, UNITED KINGDOM
We’re driven by the shared purpose of breaking new ground in the discovery of new treatments for rare diseases. Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to ...
Our Rare Treatment Accelerator helps academic, patient, and industry groups advance their rare disease drug redevelopment projects. By combining our team, expertise and financial resources with your research and insights, we can get treatments to ...
based inDoylestown, PENNSYLVANIA (USA)
Incorporated in PA in 2011, our MISSION is to translate our circulating cell-free DNA (cfDNA) in urine technology into improved cancer screening and management by liquid biopsy towards our VISION of decreased global cancer mortality. Our proprietary ...
based inPearl River, NEW YORK (USA)
Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary ...
Auro Vaccines has developed VesiculoVax™-vectored vaccines for pre- and post-exposure protection against the hemorrhagic disease caused by multiple species of filovirus (i.e. Zaire ebolavirus, Sudan ebolavirus and Marburg ...
based inAnn Arbor, MICHIGAN (USA)
Headquartered in Ann Arbor, Michigan, Cayman Chemical Company supplies scientists worldwide with the resources necessary for advancing human and animal health. We manufacture high quality biochemicals, assay kits, antibodies, and recombinant ...
based inHaifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
Femoral neck fracture is the most common form of hip fracture with annual treatment costs in the U.S. estimated to be between $10 to $15 billion, and are expected to rise due to the aging population, with mortality rates of up to 36%. *click for ...
based inDessau-Rosslau, GERMANY
IDT Biologika is an international leader in the contract development and manufacture of Viral Vaccines, Viral Vectors for Gene and Immune Therapeutics, Oncolytic Viruses, Virus-Like Particles, and other biologics. We are a full-service biologics ...
IDT Biologika is a leading viral vector CDMO with an exceptional track record in biologics manufacturing, including expertise with live viral agents. This makes us well-positioned to support the rapid growth in gene therapy and immunotherapeutics ...
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
The PrecivityAD2™ blood test is intended for patients aged 55 and older with signs or symptoms of mild cognitive impairment or dementia, who are undergoing evaluation for Alzheimer’s disease or other causes of cognitive decline. A ...
based inMineral Wells, TEXAS (USA)
Electromedical Products International, Inc. (EPI) was established in 1981 by Dr. Daniel L. Kirsch to develop, manufacture, and market Alpha-Stim® advanced medical technology worldwide. The company was launched with a sophisticated clinical model, ...
based inMilford, MASSACHUSETTS (USA)
SeraCare is a leading partner and supplier of diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers worldwide. Since the early 1980s, we have supported ...
based inKaiseraugst, SWITZERLAND
Solvias is a world leader in contract research, development and manufacturing (CRO/CDMO). The industries we serve include pharmaceuticals, biotech, medical devices and cosmetics. We provide integrated analytical services and solutions to the ...
Preformulation Package: Preformulation includes the compiling of solubility profiles (pH dependent and other systems of interest), permeability (logP/D, CaCo2 or other cell-based assays), BCS classification, accelerated chemical stability, basic ...
based inSolna, SWEDEN
Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea® ...
Docetaxel micellar is a product candidate in early clinical development and is a novel formulation that combines XR-17 with docetaxel - a well-established cytotoxin, currently administered intravenously and ...